EUVIMEDEUVIMED entdecken
Crossref

Management of daratumumab interference in Portuguese blood transfusion medicine: A literature review about unmet needs and challenges

Dialina Brilhante, Teresa Chabert, Anabela Brites, Fátima Nascimento, Maria José Rodrigues, José António Duran, Sérgio Barroso, Rita Jaime, Ana Maria Esesumaga

International Journal of Blood Transfusion and Immunohematology · 2018

DOI: 10.5348/100037z02db2018ra ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Blood Transfusion and Immunohematology, 2018. Verfasst von Dialina Brilhante und 8 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple Myeloma is a malignant disease of the bone marrow plasma cells that mainly affects older people, and whose prognosis is reserved on relapsing or refractory disease. The arrival of CD38 monoclonal antibody daratumumab into the market allowed an increase in overall survival rate, with limited associated toxicity, for pre-treated multiple myeloma patients. However, this antibody interferes with pre-transfusion tests since erythrocytes also express, even at reduced levels, CD38 receptors. A literature review and discussion about this topic was performed by a board of Portuguese Immuno-hemotherapy experts. Based on the literature review, the mechanisms by which daratumumab interferes with pre-transfusion tests and may mask the presence of irregular antibodies in plasma of treated patients, which may result in difficulties in preparing and delivering results and blood components to be transfused, were identified and discussed. In addition, the applicable strategies in clinical practice to mitigate this interference were identified, namely the denaturing method of CD38 with dithiothreitol, considered an inexpensive, reproducible, reliable and validated technique, although with logistic limitations and should not be ignored. The experts also assessed and discussed the main concerns and priorities of transfusion medicine services, considering the limitations of this technique and its implication in routines for tranfusional support. The experts agreed on the importance of communication between physicians, hematologists, immuno-hemotherapy specialists, nurses and patients, as well as the need to align all methodologies to develop global and universal protocols to the various clinical analysis laboratory centers.

Zitieren

APA

Brilhante, D., Chabert, T., Brites, A., Nascimento, F., Rodrigues, M. J., Duran, J. A., Barroso, S., Jaime, R., & Esesumaga, A. M. (2018). Management of daratumumab interference in Portuguese blood transfusion medicine: A literature review about unmet needs and challenges. International Journal of Blood Transfusion and Immunohematology. https://doi.org/10.5348/100037z02db2018ra

Vancouver

Brilhante D, Chabert T, Brites A, Nascimento F, Rodrigues MJ, Duran JA, et al. Management of daratumumab interference in Portuguese blood transfusion medicine: A literature review about unmet needs and challenges. International Journal of Blood Transfusion and Immunohematology. 2018. doi:10.5348/100037z02db2018ra

BibTeX
@article{Brilhante2018,
  author = {Brilhante, Dialina and Chabert, Teresa and Brites, Anabela and Nascimento, Fátima and Rodrigues, Maria José and Duran, José António and Barroso, Sérgio and Jaime, Rita and Esesumaga, Ana Maria},
  title = {Management of daratumumab interference in Portuguese blood transfusion medicine: A literature review about unmet needs and challenges},
  journal = {International Journal of Blood Transfusion and Immunohematology},
  year = {2018},
  doi = {10.5348/100037z02db2018ra}
}
Kostenlos starten →